Caecal leiomyoma detected by whole-body MRI in a patient with hodgkin lymphoma: First case report

Risultato della ricerca: Article

2 Citazioni (Scopus)

Abstract

Introduction. Hodgkin Lymphoma (HL) is one of the most curable malignant diseases. Modern treatments, like the combined radiochemotherapy and stem cell transplantation, have increased the number of malignant disease survivors. However, HL survivors are at risk of long-term effects, including the development of solid tumors. Secondary neoplasms are a major cause of late morbidity and mortality following treatment for HL. Case report. We report the case of a male patient, treated for HL by chemotherapy, who developed a large leiomyoma of the cecum one year after the treatment. A whole-body Magnetic Resonance (WBMRI) scan performed during the follow-up allowed the detection of this incidental caecal mass that was absent in a Computed Tomography (CT) scan performed immediately after the treatment. After a CT-guided biopsy, the lesion was surgically removed and the diagnosis of caecal leiomyoma was obtained. Discussion. To our knowledge, this is the first case report, according to the scientific literature, of caecal leiomyoma developing after chemotherapy in a HL survivor. Leiomyoma is a rare benign tumor that usually appears as a solitary small mass with a nodular growth and a benign course. Conclusion. This case shows that WB-MRI allows detecting relevant incidental findings during the oncologic follow-up, avoiding both radiation exposure and contrast agent administration. Furthermore, leiomyoma should be considered in the differential diagnosis between the caecal masses with high growth rate.
Lingua originaleEnglish
pagine (da-a)27-32
Numero di pagine6
RivistaIL GIORNALE DI CHIRURGIA
Volume38
Stato di pubblicazionePublished - 2017

Fingerprint

Leiomyoma
Hodgkin Disease
Survivors
Tomography
Literature
Drug Therapy
Neoplasms
Incidental Findings
Cecum
Stem Cell Transplantation
Chemoradiotherapy
Therapeutics
Growth
Contrast Media
Differential Diagnosis
Magnetic Resonance Spectroscopy
Morbidity
Biopsy
Mortality

All Science Journal Classification (ASJC) codes

  • Surgery

Cita questo

@article{7944e36dbbde4b1aa33cef061a0ff084,
title = "Caecal leiomyoma detected by whole-body MRI in a patient with hodgkin lymphoma: First case report",
abstract = "Introduction. Hodgkin Lymphoma (HL) is one of the most curable malignant diseases. Modern treatments, like the combined radiochemotherapy and stem cell transplantation, have increased the number of malignant disease survivors. However, HL survivors are at risk of long-term effects, including the development of solid tumors. Secondary neoplasms are a major cause of late morbidity and mortality following treatment for HL. Case report. We report the case of a male patient, treated for HL by chemotherapy, who developed a large leiomyoma of the cecum one year after the treatment. A whole-body Magnetic Resonance (WBMRI) scan performed during the follow-up allowed the detection of this incidental caecal mass that was absent in a Computed Tomography (CT) scan performed immediately after the treatment. After a CT-guided biopsy, the lesion was surgically removed and the diagnosis of caecal leiomyoma was obtained. Discussion. To our knowledge, this is the first case report, according to the scientific literature, of caecal leiomyoma developing after chemotherapy in a HL survivor. Leiomyoma is a rare benign tumor that usually appears as a solitary small mass with a nodular growth and a benign course. Conclusion. This case shows that WB-MRI allows detecting relevant incidental findings during the oncologic follow-up, avoiding both radiation exposure and contrast agent administration. Furthermore, leiomyoma should be considered in the differential diagnosis between the caecal masses with high growth rate.",
author = "Massimo Midiri and Roberto Lagalla and Antonino Agrusa and Massimo Galia and Emanuele Sinagra and {Di Buono}, Giuseppe and Donatella Narese and Domenico Albano and Caterina Patti and Dario Raimondo and Emanuele Sinagra",
year = "2017",
language = "English",
volume = "38",
pages = "27--32",
journal = "Giornale di Chirurgia",
issn = "0391-9005",
publisher = "CIC Edizioni Internazionali s.r.l.",

}

TY - JOUR

T1 - Caecal leiomyoma detected by whole-body MRI in a patient with hodgkin lymphoma: First case report

AU - Midiri, Massimo

AU - Lagalla, Roberto

AU - Agrusa, Antonino

AU - Galia, Massimo

AU - Sinagra, Emanuele

AU - Di Buono, Giuseppe

AU - Narese, Donatella

AU - Albano, Domenico

AU - Patti, Caterina

AU - Raimondo, Dario

AU - Sinagra, Emanuele

PY - 2017

Y1 - 2017

N2 - Introduction. Hodgkin Lymphoma (HL) is one of the most curable malignant diseases. Modern treatments, like the combined radiochemotherapy and stem cell transplantation, have increased the number of malignant disease survivors. However, HL survivors are at risk of long-term effects, including the development of solid tumors. Secondary neoplasms are a major cause of late morbidity and mortality following treatment for HL. Case report. We report the case of a male patient, treated for HL by chemotherapy, who developed a large leiomyoma of the cecum one year after the treatment. A whole-body Magnetic Resonance (WBMRI) scan performed during the follow-up allowed the detection of this incidental caecal mass that was absent in a Computed Tomography (CT) scan performed immediately after the treatment. After a CT-guided biopsy, the lesion was surgically removed and the diagnosis of caecal leiomyoma was obtained. Discussion. To our knowledge, this is the first case report, according to the scientific literature, of caecal leiomyoma developing after chemotherapy in a HL survivor. Leiomyoma is a rare benign tumor that usually appears as a solitary small mass with a nodular growth and a benign course. Conclusion. This case shows that WB-MRI allows detecting relevant incidental findings during the oncologic follow-up, avoiding both radiation exposure and contrast agent administration. Furthermore, leiomyoma should be considered in the differential diagnosis between the caecal masses with high growth rate.

AB - Introduction. Hodgkin Lymphoma (HL) is one of the most curable malignant diseases. Modern treatments, like the combined radiochemotherapy and stem cell transplantation, have increased the number of malignant disease survivors. However, HL survivors are at risk of long-term effects, including the development of solid tumors. Secondary neoplasms are a major cause of late morbidity and mortality following treatment for HL. Case report. We report the case of a male patient, treated for HL by chemotherapy, who developed a large leiomyoma of the cecum one year after the treatment. A whole-body Magnetic Resonance (WBMRI) scan performed during the follow-up allowed the detection of this incidental caecal mass that was absent in a Computed Tomography (CT) scan performed immediately after the treatment. After a CT-guided biopsy, the lesion was surgically removed and the diagnosis of caecal leiomyoma was obtained. Discussion. To our knowledge, this is the first case report, according to the scientific literature, of caecal leiomyoma developing after chemotherapy in a HL survivor. Leiomyoma is a rare benign tumor that usually appears as a solitary small mass with a nodular growth and a benign course. Conclusion. This case shows that WB-MRI allows detecting relevant incidental findings during the oncologic follow-up, avoiding both radiation exposure and contrast agent administration. Furthermore, leiomyoma should be considered in the differential diagnosis between the caecal masses with high growth rate.

UR - http://hdl.handle.net/10447/239752

UR - http://www.giornalechirurgia.it

M3 - Article

VL - 38

SP - 27

EP - 32

JO - Giornale di Chirurgia

JF - Giornale di Chirurgia

SN - 0391-9005

ER -